A detailed history of New York State Common Retirement Fund transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 36,979 shares of ARWR stock, worth $685,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,979
Previous 51,079 27.6%
Holding current value
$685,590
Previous $1.33 Million 46.08%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$19.36 - $29.54 $272,976 - $416,514
-14,100 Reduced 27.6%
36,979 $716,000
Q2 2024

Jul 31, 2024

BUY
$21.87 - $28.24 $106,703 - $137,782
4,879 Added 10.56%
51,079 $1.33 Million
Q1 2024

May 07, 2024

BUY
$27.21 - $39.48 $152,376 - $221,087
5,600 Added 13.79%
46,200 $1.32 Million
Q4 2023

Feb 01, 2024

SELL
$21.2 - $31.03 $48,039 - $70,313
-2,266 Reduced 5.29%
40,600 $1.24 Million
Q3 2023

Nov 07, 2023

BUY
$26.2 - $36.08 $26,173 - $36,043
999 Added 2.39%
42,866 $1.15 Million
Q2 2023

Aug 07, 2023

SELL
$25.16 - $41.38 $285,138 - $468,959
-11,333 Reduced 21.3%
41,867 $1.49 Million
Q1 2023

May 02, 2023

SELL
$23.68 - $38.51 $7.08 Million - $11.5 Million
-299,022 Reduced 84.9%
53,200 $1.35 Million
Q4 2022

Jan 30, 2023

BUY
$28.0 - $40.56 $89,600 - $129,792
3,200 Added 0.92%
352,222 $14.3 Million
Q3 2022

Nov 08, 2022

SELL
$29.63 - $48.31 $562 - $917
-19 Reduced 0.01%
349,022 $11.5 Million
Q2 2022

Aug 04, 2022

BUY
$27.79 - $50.61 $17,202 - $31,327
619 Added 0.18%
349,041 $12.3 Million
Q1 2022

May 05, 2022

SELL
$39.62 - $69.97 $34,588 - $61,083
-873 Reduced 0.25%
348,422 $16 Million
Q4 2021

Feb 02, 2022

BUY
$58.09 - $82.51 $81,500 - $115,761
1,403 Added 0.4%
349,295 $23.2 Million
Q3 2021

Nov 02, 2021

SELL
$58.38 - $84.96 $1.66 Million - $2.42 Million
-28,433 Reduced 7.56%
347,892 $21.7 Million
Q2 2021

Aug 02, 2021

BUY
$62.15 - $90.32 $590,611 - $858,310
9,503 Added 2.59%
376,325 $31.2 Million
Q1 2021

May 11, 2021

SELL
$61.35 - $90.47 $587,119 - $865,797
-9,570 Reduced 2.54%
366,822 $24.3 Million
Q4 2020

Feb 08, 2021

BUY
$43.82 - $85.37 $423,739 - $825,527
9,670 Added 2.64%
376,392 $28.9 Million
Q3 2020

Nov 05, 2020

SELL
$33.21 - $51.27 $79,704 - $123,048
-2,400 Reduced 0.65%
366,722 $15.8 Million
Q2 2020

Aug 07, 2020

BUY
$26.12 - $43.27 $222,020 - $367,795
8,500 Added 2.36%
369,122 $15.9 Million
Q4 2019

Feb 05, 2020

SELL
$28.14 - $73.01 $371,448 - $963,732
-13,200 Reduced 3.53%
360,622 $22.9 Million
Q3 2019

Nov 07, 2019

SELL
$26.26 - $34.86 $461,388 - $612,490
-17,570 Reduced 4.49%
373,822 $10.5 Million
Q2 2019

Aug 09, 2019

BUY
$17.43 - $28.82 $343,981 - $568,762
19,735 Added 5.31%
391,392 $10.4 Million
Q1 2019

May 08, 2019

BUY
$12.05 - $20.18 $120,921 - $202,506
10,035 Added 2.77%
371,657 $6.82 Million
Q4 2018

Feb 08, 2019

BUY
$10.74 - $19.7 $2.84 Million - $5.21 Million
264,422 Added 272.04%
361,622 $4.49 Million
Q3 2018

Nov 07, 2018

BUY
$14.0 - $20.3 $7,000 - $10,150
500 Added 0.52%
97,200 $1.86 Million
Q2 2018

Aug 10, 2018

BUY
$6.37 - $14.02 $615,979 - $1.36 Million
96,700 New
96,700 $1.32 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.